Fed's Barkin (2027 voter) says 2% inflation is not some unicorn, is something we can hit
Every headline is on the live feed 20 minutes before this site.
Fed's Barkin (2027 voter) says 2% inflation is not some unicorn, is something we can hit
US VP Vance says using Defense Production Act to expand a Texas refinery; working with Delek (DK) to expand this refinery
US Treasury sells 6-wk bills at high-rate 3.980%, B/C 2.58x
On the Newsquawk feed at , 20 minutes before this page.
Context
Commentary of this kind from a non-voting regional president tends to move the front end only modestly; Barkin has no vote until 2027, so the remarks function as sentiment colour rather than an input to the near-term policy path. The substance, an insistence that 2% is attainable rather than a pretext for accepting a higher de facto target, places him against the periodic strand of argument that the target should be revised upward or that the last mile is not worth the cost. Historically that debate resurfaces whenever disinflation stalls, and officials' responses to it split along familiar lines: those stressing target credibility have tended to favour keeping policy restrictive for longer, while those emphasising employment costs have leant toward earlier easing. Single-speaker remarks of this type have typically repriced only when they signal where the committee's centre of gravity sits, so the follow-on that matters is whether more senior figures echo the framing. The distinction worth drawing is between reaffirming the target, which supports the back end through anchored expectations, and any signal about the timing of cuts, which is a front-end story; these remarks address the former. The immediate tells are the reaction in breakevens rather than nominal yields, and whether subsequent speakers adopt or dilute the same language.
Related headlines
- Fed's Goolsbee (2027 Voter) says AI is an inflation problem, inflation is still way too high, reports Semafor6 hours ago
- [MARKET ANALYSIS] Fixed remains at APAC highs after the tech sell-off and energy downside, Gilts react to fiscal updates/reports8 hours ago
- [MARKET ANALYSIS] DXY pressured alongside easing yields/energy prices; JPY gains on reports that the BoJ may adjust inflation target language8 hours ago
- Newsquawk European Market Wrap - 13th October 20263 hours ago
- Treasury Block Trades [Rolling headline, 13th October 2026]4 hours ago
- US EQUITY OPEN: NDX underperforms as memory name sell-off continues as US earnings season begins3 hours ago
- Israeli President Netanyahu spoke with US President Trump last week about renewing the war on Iran41 min ago
- US President Trump says Houthis are behaving very badly; Somebody should explain to them that I’m not running in the elections, I’ve already won, but I’ll be there after the elections, and I will never forget1 hour ago
- US President Trump says he is working with Russia and Ukraine on ending the war; thinks both Zelensky and Putin want it to end2 hours ago
- Israeli Defense Minister says anyone who attacks us "before or after the elections" will have their hand cut off and will pay the price, Al Hadath reports40 min ago
- US President Trump to campaign in Kansas on October 19th, according to Politico53 min ago
- US President Trump praises US Navy blockade vs Iran1 hour ago
- Republican Senators reportedly urge US President Trump to back out of his Russian oil deal2 hours ago
- Indian Foreign Minister Jaishankar says India and US trade talks are heading in the right direction and a deal is currently being ironed out2 hours ago
- Saudi Arabia targeted the Ras Issa area in Hodeidah, Yemen with airstrikes, Yemeni media also reported a Saudi artillery attack on areas in the Shada border area; reports Fars citing Al Jazeera field sources2 hours ago
- Russian President Putin holds a phone call with UAE's President and discussed Middle East and diesel deal with US 5 hours ago
- The political official of the IRGC says US President Trump is facing internal pressure, and we cannot bear the cost of this state of neither war nor peace alone6 hours ago
- BioNTech (BNTX) announced that the AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy candidate BNT113 plus pembrolizumab compared with pembrolizumab alone6 hours ago
- Anthropic and OpenAI have reportedly sought significant control over what outside evaluators can publish, highlighting concerns that findings could reveal trade secrets, according to reports7 hours ago
- German government official says the recent EU-China trade agreement is a step in the right direction but does not solve the overall issue of the large deficit7 hours ago
The feed had this first.
Use the Platform